2023 annual financial data
Arbutus Biopharma 2023 Operating margin
Direct answer
Operating margin was -430.53%.
Operating income was -78,103,000 USD and net income was -72,849,000 USD.
Operating cash flow was -85,936,000 USD.
Get free Arbutus Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 18,141,000 USD
- Operating income
- -78,103,000 USD
- Net income
- -72,849,000 USD
- Operating cash flow
- -85,936,000 USD